| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Graduate School of Comprehensive Human Sciences, Center for Tsukuba Advanced Research Alliance, and ERATO Environmental Research Project, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba 305-8577, Japan
2 Tohoku University Biomedical Engineering Research Organization, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan
Transcription factor GATA-2 is expressed in a number of tissues, including hematopoietic stem and progenitor cells, and is crucial for the proliferation and survival of hematopoietic cells. To further characterize the function of GATA-2, we examined the cellular turnover mechanism of GATA-2. In P815 cells, the half-life of endogenous GATA-2 was found to be as short as 30 min after cycloheximide treatment. This short half-life was reproducible in other hematopoietic and neuroblastoma cell lines with moderate variation. We also found that ultraviolet (UV)-C irradiation markedly represses the GATA-2 protein level by facilitating the degradation process. Since treatment of the cells with the proteasome inhibitor MG132 or clasto-Lactacystin substantially abrogated the effects of cycloheximide and UV-C irradiation and increased the expression level of both endogenous and transfected GATA-2, the degradation of GATA-2 seems to occur through the proteasome pathway. Structure-function analyses with the GAL4-DNA binding domain (GBD)-GATA-2 fusion protein and GATA-2 deletion mutants suggested that the protein degradation regulatory elements of GATA-2 reside in three regions, two of which overlap with the transactivation domain. We also detected poly ubiquitinated forms of GATA-2. Taken together, these results demonstrate that GATA-2 is turned over rapidly through the ubiquitin-proteasome pathway.
* Correspondence: E-mail: masi{at}tara.tsukuba.ac.jp; nmine{at}tubero.tohoku.ac.jp
This article has been cited by other articles:
|
|
 |
|
  T. Tripic, W. Deng, Y. Cheng, Y. Zhang, C. R. Vakoc, G. D. Gregory, R. C. Hardison, and G. A. Blobel SCL and associated proteins distinguish active from repressive GATA transcription factor complexes Blood, March 5, 2009; 113(10): 2191 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Guinez, A.-M. Mir, V. Dehennaut, R. Cacan, A. Harduin-Lepers, J.-C. Michalski, and T. Lefebvre Protein ubiquitination is modulated by O-GlcNAc glycosylation FASEB J, August 1, 2008; 22(8): 2901 - 2911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Han, L. Zhong, A. Srivastava, and P. W. Stacpoole Pyruvate Dehydrogenase Complex Deficiency Caused by Ubiquitination and Proteasome-mediated Degradation of the E1 Subunit J. Biol. Chem., January 4, 2008; 283(1): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ferreira, A. Wai, R. Shimizu, N. Gillemans, R. Rottier, M. von Lindern, K. Ohneda, F. Grosveld, M. Yamamoto, and S. Philipsen Dynamic regulation of Gata factor levels is more important than their identity Blood, June 15, 2007; 109(12): 5481 - 5490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Koga, N. Yamaguchi, T. Abe, M. Minegishi, S. Tsuchiya, M. Yamamoto, and N. Minegishi Cell-cycle-dependent oscillation of GATA2 expression in hematopoietic cells Blood, May 15, 2007; 109(10): 4200 - 4208. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |
